Network-based prediction of drug combinations with quantum annealing

• URL: http://arxiv.org/abs/2512.20199v1
• Date: Tue, 23 Dec 2025 09:47:00 GMT
• Title: Network-based prediction of drug combinations with quantum annealing
• Authors: Diogo Ramos, Bruno Coutinho, Duarte Magano,
• Abstract summary: We propose a quantum annealing-based algorithm for identifying effective drug combinations.<n>We test our method for Diabetes Mellitus, Rheumatoid Arthritis, Asthma, and Brain Neoplasms, relying on experimentally validated drug combinations.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: The systematic discovery of effective drug combinations is a challenging problem in modern pharmacology, driven by the combinatorial growth of potential pairings and dosage configurations. Network medicine, modeling diseases and drugs as interconnected modules of the human protein-protein interactome, has emerged as a new paradigm for understanding disease mechanisms and drug action. In this work, we propose a quantum annealing-based algorithm for identifying effective drug combinations. Underlying our approach is the biologically motivated principle of `Complementary Exposure', which posits that therapeutic drug combinations target distinct yet complementary regions of a disease module. We translate this into a quadratic unconstrained binary optimisation problem. We test our method for Diabetes Mellitus, Rheumatoid Arthritis, Asthma, and Brain Neoplasms, relying on experimentally validated drug combinations for these diseases. Our simulated quantum annealing experiments reveal that low-energy configurations align with biologically plausible combinations, demonstrating the algorithm's ability to generate novel predictions for drug combinations.

Related papers

• Large Language Models in Drug Discovery and Development: From Disease Mechanisms to Clinical Trials [49.19897427783105]
  The integration of Large Language Models (LLMs) into the drug discovery and development field marks a significant paradigm shift. We investigate how these advanced computational models can uncover target-disease linkage, interpret complex biomedical data, enhance drug molecule design, predict drug efficacy and safety profiles, and facilitate clinical trial processes.
  arXiv  Detail & Related papers  (2024-09-06T02:03:38Z)
• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• SynerGPT: In-Context Learning for Personalized Drug Synergy Prediction and Drug Design [64.69434941796904]
  We propose a novel setting and models for in-context drug synergy learning. We are given a small "personalized dataset" of 10-20 drug synergy relationships in the context of specific cancer cell targets. Our goal is to predict additional drug synergy relationships in that context.
  arXiv  Detail & Related papers  (2023-06-19T17:03:46Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Neural Bandits for Data Mining: Searching for Dangerous Polypharmacy [63.135687276599114]
  Some polypharmacies, deemed inappropriate, may be associated with adverse health outcomes such as death or hospitalization. We propose the OptimNeuralTS strategy to efficiently mine claims datasets and build a predictive model of the association between drug combinations and health outcomes. Our method can detect up to 72% of PIPs while maintaining an average precision score of 99% using 30 000 time steps.
  arXiv  Detail & Related papers  (2022-12-10T03:43:23Z)
• RECOVER: sequential model optimization platform for combination drug repurposing identifies novel synergistic compounds in vitro [46.773794687622825]
  We employ a sequential model optimization search applied to a deep learning model to quickly discover highly synergistic drug combinations active against a cancer cell line. We find that the set of combinations queried by our model is enriched for highly synergistic combinations. Remarkably, we rediscovered a synergistic drug combination that was later confirmed to be under study within clinical trials.
  arXiv  Detail & Related papers  (2022-02-07T02:54:29Z)
• DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations [0.9854322576538699]
  computational screening has become an important way to prioritize drug combinations. DeepDDS was superior to competitive methods by more than 16% predictive precision.
  arXiv  Detail & Related papers  (2021-07-06T08:25:43Z)
• Discovering Synergistic Drug Combinations for COVID with Biological Bottleneck Models [38.637412590671865]
  We propose a emphbiological bottleneck model that jointly learns drug-target interaction and synergy. The model consists of two parts: a drug-target interaction and target-disease association module. We experimentally tested the model predictions in the U.S. National Center for Advancing Translational Sciences.
  arXiv  Detail & Related papers  (2020-11-09T03:30:44Z)
• Network-principled deep generative models for designing drug combinations as graph sets [13.920460847160605]
  Combination therapy has shown to improve therapeutic efficacy while reducing side effects. Facing enormous chemical space and unclear design principles for small-molecule combinations, the computational drug-combination design has not seen generative models to meet its potential to accelerate resistance-overcoming drug combination discovery. We have developed the first deep generative model for drug combination design, by jointly embedding graph-structured domain knowledge and iteratively training a reinforcement learning-based chemical graph-set designer.
  arXiv  Detail & Related papers  (2020-04-16T17:22:39Z)
• A Node Embedding Framework for Integration of Similarity-based Drug Combination Prediction [7.4517333921953215]
  We propose a Network Embedding framework in Multiplex Networks (NEMN) to predict synthetic drug combinations. Based on a multiplex drug similarity network, we offered alternative methods to integrate useful information from different aspects. For Drug combination prediction, we found seven novel drug combinations which have been validated by external sources.
  arXiv  Detail & Related papers  (2020-02-25T02:24:47Z)
• Prediction of Drug Synergy by Ensemble Learning [0.0]
  We investigate the effectiveness of different compound representations in predicting the drug synergy. On a large drug combination screen dataset, we first demonstrate the use of a promising representation that has not been used for this problem before. We then propose an ensemble on representation-model combinations that outperform each of the baseline models.
  arXiv  Detail & Related papers  (2020-01-07T12:21:37Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.